StockData

Liminatus Pharma, Inc. (LIMN) stock

LIMNNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31Also trades as LIMNW
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Aug 14, 2026Score 2/30
$2.68−0.13 (-4.63%)

Close on Nov 18, 2026Market cap $179.99MP/E –Yield –

Liminatus Pharma pe ratio

The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.

No pe ratio figures for Liminatus Pharma

Liminatus Pharma has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

More Liminatus Pharma figures

See a number that looks wrong?